Last updated on December 2018

A Registry for Patients Taking Uptravi

Brief description of study

This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.

Clinical Study Identifier: NCT03278002

Find a site near you

Start Over

University of Virginia System

Charlottesville, VA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.